Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263].
European Urology Oncology（2021）
关键词
Renal cell carcinoma,Framingham Risk Score,MEDLINE,Oncology,Medicine,Cytoreductive nephrectomy,Internal medicine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要